MedCity News

FEBRUARY 6, 2025

Currently available therapies for Hunter syndrome dont cross the blood-brain barrier to address cognitive symptoms of the inherited enzyme deficiency. Denali Therapeutics’ technology gets its drug across the protective membrane, and the biotech plans to seek accelerated FDA approval in this rare disease. The post Denalis Data in Rare Enzyme Deficiency Keep It on Pace to Seek Speedy FDA Approval appeared first on MedCity News.

FDA 254

FDA Biopharma Pharma 254

PharmaVoice

FEBRUARY 6, 2025

The market has been no less demanding for pharma giants as 2025 begins, but last year’s strategies are paying off.

Pharma 130

Pharma Marketing 130

MedCity News

FEBRUARY 6, 2025

Teladoc Health’s acquisition of Catapult Health will add “another channel” to funnel patients into Teladoc’s chronic care programs, according to one healthcare expert. The post Why Teladoc Health is Acquiring Catapult Health for $65M appeared first on MedCity News.

Healthcare 184

Healthcare Healthcare Patients 184

pharmaphorum

FEBRUARY 6, 2025

BMS is extending its bid to cut costs by $1.5bn before the end of this year, backed by 2,200 job cuts, adding a target of another $2bn by end-2027.

93

93

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

PharmaTimes

FEBRUARY 6, 2025

Designation follows promising preclinical data and FDA clearance

FDA 91

FDA 91

PharmaTimes

FEBRUARY 6, 2025

Partnership aims to leverage cutting-edge technology in clinical trials

68

68

pharmaphorum

FEBRUARY 6, 2025

AstraZeneca's exposure to liability in a Chinese investigation into illegal drug imports appears to be much less than had been feared.

66

66

Pharmaceutical Technology

FEBRUARY 6, 2025

CagriSema, considered a successor to Wegovy, is Novo Nordisks most likely route of gaining GLP-1RA market share back from Eli Lilly.

Marketing 64

Marketing 64

PharmaTech

FEBRUARY 6, 2025

A new bioanalytical lab being opened by Ardena at the site is expected to be operational by the third quarter of 2025.

Manufacturing 59

Manufacturing 59

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

Pharmaceutical Technology

FEBRUARY 6, 2025

The UK-based drugmaker reported a 21% increase in annual revenues, reaching 43bn ($54.1bn) in 2024.

59

59

PharmaTech

FEBRUARY 6, 2025

Hood, a pioneer of systems biology and systems medicine, shared his personal interest in starting a new peptide-based, informational-driven pharmaceutical company that would address wellness and longevity.

Medicine 59

Medicine Pharmaceutical 59

Pharmaceutical Technology

FEBRUARY 6, 2025

The FDA has granted orphan drug designation (ODD) and RPDD to Arbor Biotechnologies' ABO-101, to treat primary hyperoxaluria type 1 (PH1).

FDA 59

FDA 59

Pharmacy Times

FEBRUARY 6, 2025

There were no substantial differences for the mindfulness with substance use or anxiety outcomes compared with the recovery control group.

53

53

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

Pharmaceutical Technology

FEBRUARY 6, 2025

EVA Pharma of Africa, DNA Script and Quantoom Biosciences have signed a MoU to establish the mRNA production platform in Egypt.

Pharma 59

Pharma 59

PharmaTech

FEBRUARY 6, 2025

Webinar Date/Time: Tuesday, March 11, 2025 | 11:00 AM EDT / 3:00 PM GMT

Manufacturing 52

Manufacturing 52

Pharmaceutical Technology

FEBRUARY 6, 2025

The US Food and Drug Administration (FDA) rejected three prior regulatory applications before granting approval.

Food and Drug Administration 59

Food and Drug Administration FDA Food 59

Pharmatutor

FEBRUARY 6, 2025

How to Get a Pharmacy Job in Australia with the OPRA Exam? admin Thu, 02/06/2025 - 16:25 Overseas Pharmacist Readiness Assessment, or the OPRA exam, is a single-paper test conducted by the Australian Pharmacy Council. This is a part of the skills assessment process by the APC, which aims to test the competency of global pharmacists before offering them registration in Australia.

52

52

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy

Pharmaceutical Technology

FEBRUARY 6, 2025

The USPTO has granted a patent to Vistagens non-opioid oral product candidate AV-101 for neuropathic pain treatment.

59

59

Pharmaceutical Commerce

FEBRUARY 6, 2025

Finding the optimal balance in pharmacy benefit manager reform.

Patients 52

Patients Management 52

PharmExec

FEBRUARY 6, 2025

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, and prednisone against the current standard-of-care in patients with previously untreated diffuse large B-cell lymphoma.

Patients 52

Patients 52

Pharmaceutical Commerce

FEBRUARY 6, 2025

New engagement approaches can help drive treatment gains in underrepresented communities.

52

52

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

PharmaTech

FEBRUARY 6, 2025

Rapid market growth in biologics is helping the packaging market expand as well, but the complex nature of biologics and the desire for personalized therapies present unique hurdles to make packaging solutions cost-effective and safe for patients.

Marketing 52

Marketing Patients 52

Pharmaceutical Commerce

FEBRUARY 6, 2025

A look at the actionable steps needed to elicit change.

Manufacturing 52

Manufacturing 52

PharmExec

FEBRUARY 6, 2025

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI identifies potential disruptions AI-driven models could have to the current R&D practices in the industry.

Pharmaceutical 52

Pharmaceutical 52

Pharmaceutical Commerce

FEBRUARY 6, 2025

A survey study of US employers aims to determine whether they prioritize financial or nonfinancial criteria when selecting health plans.

52

52

Advertiser: ZoomInfo

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

Prospecting

PharmExec

FEBRUARY 6, 2025

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52

Pharma 52

Pharmaceutical Commerce

FEBRUARY 6, 2025

The latest news for pharma industry insiders.

Pharma 52

Pharma 52

PharmExec

FEBRUARY 6, 2025

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharmaceutical 52

Pharmaceutical 52